Moderna President Stephen Hoge Files Form 144 to Sell $5.81M in Stock
Moderna, Inc.
Subscribe to track MRNA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š¢ Form 144 Proposed Sale Notice: Moderna, Inc. ($MRNA) š¤ Insider: Stephen Hoge (Officer) š Notice Date: September 14, 2026 š Proposed Sale: 40,294 shares (~$5,807,746) š Acquisition Nature: Stock Option Exercise (Cash payment on 09/14/2026) āļø Rule 10b5-1 Plan Date: June 15, 2026 šļø Broker: Fidelity Brokerage Services LLC
Comprehensive Analysis
Insider Filing Analysis: Moderna, Inc. (Form 144)
Overview: On September 14, 2026, Dr. Stephen Hoge, an Officer (President) of Moderna, Inc. ($MRNA), filed a Form 144 notice indicating the proposed sale of 40,294 shares of Common Stock through Fidelity Brokerage Services LLC, valued at approximately $5,807,745.84 (~$144.13 per share).
Acquisition & Execution:
- Acquisition Source: The shares are to be acquired via cash exercise of stock options on September 14, 2026.
- Trading Plan: The transaction is governed by a pre-arranged trading plan adopted on June 15, 2026, pursuant to Rule 10b5-1.
Recent Trading Activity (Past 3 Months):
- June 15, 2026: Sold 53,336 shares for gross proceeds of $2,739,870.32.
- July 15, 2026: Sold 53,336 shares for gross proceeds of $3,605,513.60.
Market Impact & Significance:
- Significance Level: Medium.
- The planned sale represents an ongoing, scheduled exercise-and-sell pattern under a Rule 10b5-1 trading plan established earlier in 2026. The 40,294 shares represent a minor fraction of the 399.2 million shares outstanding.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.